ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|18|15|1810-1816

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.15, 2017-10, pp. : 1810-1816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs

By  

Current Drug Targets, Vol. 7, Iss. 12, 2006-12 ,pp. : 1671-1680

Bentham Science Publishers

Access to resources Recommend Favorite

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms

By Gunes Arzu   Dahl Marja-Liisa  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 625-637

Future Medicine

Access to resources Recommend Favorite

Population Distribution of Aldehyde Dehydrogenase-2 Genetic Polymorphism: Implications for Risk Assessment

By Ginsberg G.   Smolenski S.   Hattis D.   Sonawane B.  

Regulatory Toxicology and Pharmacology, Vol. 36, Iss. 3, 2002-12 ,pp. : 297-309

Academic Press

Access to resources Recommend Favorite

Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

By Desta Z.   Zhao X.   Shin J-G.   Flockhart D.A.  

Clinical Pharmacokinetics, Vol. 41, Iss. 12, 2002-01 ,pp. : 913-958

Adis International

Access to resources Recommend Favorite

Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity

By Neafsey Pat  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 362-388

Taylor & Francis Ltd

Access to resources Recommend Favorite